The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Current status and therapeutic considerations of hypertension in the elderly

  • Lee, Ju-Hee (Division of Cardiology, Department of Internal Medicine, Chungbuk National University Hospital) ;
  • Kim, Kwang-Il (Department of Internal Medicine, Seoul National University Bundang Hospital) ;
  • Cho, Myeong-Chan (Department of Internal Medicine, Chungbuk National University College of Medicine)
  • Received : 2019.06.14
  • Accepted : 2019.06.21
  • Published : 2019.07.01
⟨ Previous Next ⟩

Abstract

As the prevalence of hypertension in the elderly population is increasing, information regarding the characteristics, optimal blood pressure targets, and special considerations for elderly hypertensive patients is needed to improve clinical outcomes. Various factors should be considered when managing hypertension in elderly patients, and there are many controversial issues and conflicting results related to the optimal treatment of hypertension in the elderly. In this review, we provide an overview of the epidemiology and characteristics of elderly hypertensive patients and discuss the optimal treatment of hypertension in elderly people.

Keywords

Acknowledgement

This research was supported by a fund (2018-ER6303-00) by Research of Korea Centers for Disease Control and Prevention.

References

  1. Korean Society Hypertension (KSH); Hypertension Epidemiology Research Working Group, Kim HC, Cho MC. Korea hypertension fact sheet 2018. Clin Hypertens 2018;24:13. https://doi.org/10.1186/s40885-018-0098-0
  2. Korean Statistical Information Service. 2017 Population and housing census [Internet]. Daejeon (KR): Statistics Korea, 2018 [cited 2019 Jun 21]. Available from: http://kosis.kr.
  3. Korean Statistical Information Service. Medical service usage statistics by region [Internet]. Daejeon (KR): Statistics Korea, 2018 [cited 2019 Jun 21]. Available from: http://kosis.kr.
  4. Korean Statistical Information Service. 2017 Cause of death statistics [Internet]. Daejeon (KR): Statistics Korea, 2018 [cited 2019 Jun 21]. Available from: http://kosis.kr.
  5. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383. https://doi.org/10.1016/0021-9681(87)90171-8
  6. Najjar SS, Scuteri A, Lakatta EG. Arterial aging: is it an immutable cardiovascular risk factor? Hypertension 2005;46:454-462. https://doi.org/10.1161/01.HYP.0000177474.06749.98
  7. Oh YS. Arterial stiffness and hypertension. Clin Hypertens. 2018;24:17. https://doi.org/10.1186/s40885-018-0102-8
  8. Kim KI, Cho YS, Choi DJ, Kim CH. Optimal treatment of hypertension in the elderly: a Korean perspective. Geriatr Gerontol Int 2008;8:5-11. https://doi.org/10.1111/j.1447-0594.2008.00440.x
  9. O'Rourke MF, Adji A. An updated clinical primer on large artery mechanics: implications of pulse waveform analysis and arterial tonometry. Curr Opin Cardiol 2005;20:275-281. https://doi.org/10.1097/01.hco.0000166595.44711.6f
  10. Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation 2003;107:490-497. https://doi.org/10.1161/01.CIR.0000048894.99865.02
  11. Xu X, Wang B, Ren C, et al. Age-related impairment of vascular structure and functions. Aging Dis 2017;8:590-610. https://doi.org/10.14336/AD.2017.0430
  12. Nilsson PM. Early vascular aging (EVA): consequences and prevention. Vasc Health Risk Manag 2008;4:547-552. https://doi.org/10.2147/VHRM.S1094
  13. Zweifler AJ, Shahab ST. Pseudohypertension: a new assessment. J Hypertens 1993;11:1-6. https://doi.org/10.1097/00004872-199301000-00001
  14. Kjeldsen SE, Stenehjem A, Os I, et al. Treatment of high blood pressure in elderly and octogenarians: European Society of Hypertension statement on blood pressure targets. Blood Press 2016;25:333-336. https://doi.org/10.1080/08037051.2016.1236329
  15. Kario K. New insight of morning blood pressure surge into the triggers of cardiovascular disease-synergistic resonance of blood pressure variability. Am J Hypertens 2016;29:14-16. https://doi.org/10.1093/ajh/hpv114
  16. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 2012;380:37-43. https://doi.org/10.1016/S0140-6736(12)60240-2
  17. Wong MC, Wang HH, Cheung CS, et al. Factors associated with multimorbidity and its link with poor blood pressure control among 223,286 hypertensive patients. Int J Cardiol 2014;177:202-208. https://doi.org/10.1016/j.ijcard.2014.09.021
  18. Klein BE, Klein R, Knudtson MD, Lee KE. Frailty, morbidity and survival. Arch Gerontol Geriatr 2005;41:141-149. https://doi.org/10.1016/j.archger.2005.01.002
  19. Mitnitski A, Collerton J, Martin-Ruiz C, et al. Age-related frailty and its association with biological markers of ageing. BMC Med 2015;13:161. https://doi.org/10.1186/s12916-015-0400-x
  20. Kang MG, Kim SW, Yoon SJ, Choi JY, Kim KI, Kim CH. Association between frailty and hypertension prevalence, treatment, and control in the elderly Korean population. Sci Rep 2017;7:7542. https://doi.org/10.1038/s41598-017-07449-5
  21. SPRINT Research Group, Wright JT Jr, Williamson JD, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015;373:2103-2116. https://doi.org/10.1056/NEJMoa1511939
  22. Williamson JD, Supiano MA, Applegate WB, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial. JAMA 2016;315:2673-2682. https://doi.org/10.1001/jama.2016.7050
  23. Supiano MA, Williamson JD. Applying the systolic blood pressure intervention trial results to older adults. J Am Geriatr Soc 2017;65:16-21. https://doi.org/10.1111/jgs.14681
  24. Peters R, Beckett N, Forette F, et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVETCOG): a double-blind, placebo controlled trial. Lancet Neurol 2008;7:683-689. https://doi.org/10.1016/S1474-4422(08)70143-1
  25. SPRINT MIND Investigators for the SPRINT Research Group, Williamson JD, Pajewski NM, et al. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial. JAMA 2019;321:553-561. https://doi.org/10.1001/jama.2018.21442
  26. Jung HW, Kim KI. Blood pressure variability and cognitive function in the elderly. Pulse (Basel) 2013;1:29-34. https://doi.org/10.1159/000348622
  27. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358:1887-1898. https://doi.org/10.1056/NEJMoa0801369
  28. Warwick J, Falaschetti E, Rockwood K, et al. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Med 2015;13:78. https://doi.org/10.1186/s12916-015-0328-1
  29. JATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res 2008;31:2115-2127. https://doi.org/10.1291/hypres.31.2115
  30. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation 2018;138:e484-e594.
  31. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J 2018;39:3021-3104. https://doi.org/10.1093/eurheartj/ehy339

Cited by

  1. Updated Reasons and Clinical Implications of New Korean Hypertension Guidelines for Cardiologists vol.50, pp.6, 2020, https://doi.org/10.4070/kcj.2019.0338
  2. Renin-angiotensin system modulators and other risk factors in COVID-19 patients with hypertension: a Korean perspective vol.21, pp.1, 2019, https://doi.org/10.1186/s12879-021-05848-8